the nucleus or in the cytoplasm. Upon protein misfolding, HSF1 translocates to the nucleus and drives transcription [2] . Two protein kinases, MEK and AMPK have been shown to promote or inhibit HSF1 nuclear translocation, respectively [12, 13] , (3) DNA binding and transcriptional activation: HSF1 DNA binding ability is impaired by acetylation in the DNA binding domain by the acetyltransferase p300/CBP leading to attenuation of the HSR [8, 14, 15] . The deacetylases SIRT1, HDAC7 and HDAC9 enhance the HSR by increasing the dwell time of HSF1 on DNA [14, 16] . Co-activators including the Mediator complex, and repressors such as PGC-1α have been proposed to promote or suppress HSF1 transcriptional activity at its target promoters [17] [18] [19] , and (4) Protein stability: The E3 ligases FBXW7 and NEDD4 have been shown to target HSF1 for degradation by the ubiquitin proteasome system [20, 21] , with FBXW7 mediated degradation being promoted by phosphorylation of HSF1 by the ERK, GSK3β and CK2 α' kinases [20, 22] .
Because the HSR has been characterized predominantly in yeast and dissected tissues or tissue culture cells of animals, and expression of HSF1 is ubiquitous, it was widely thought that the magnitude, kinetics, and duration of the HSR are determined solely by the stress conditions encountered. Likewise, HSF1 has been generally considered to function only in the classical HSR to protect cellular health and tissue physiology. However, accumulating evidence in metazoans have challenged these traditional viewpoints and suggest that the HSR is tailored to specific cellular needs and regulated by cell-non-autonomous control through communication between tissues [23] [24] [25] . Further, HSF1 directs transcriptional programs in development and metabolism [26, 27] that are distinct from the classical HSR. These non-canonical HSF1 transcriptional programs influence the PN and other cellular functions in aging and disease in addition to the HSR [25, 28] .
Regulation of HSF1 by the proliferative and metabolic states of the cell
Among the known regulators of HSF1 are proteins that also function in growth factor signaling or nutrient sensing pathways (Figure 2 ), suggesting that HSF1 and the HSR is influenced by the proliferative and metabolic states of the cell, thus providing a means for the cell to tailor the activity of HSF1 and the potency of the HSR to specific needs and cellular context. For example, MEK kinase of the RAS/MAPK pathway phosphorylates HSF1 at Ser326, which promotes both HSF1 nuclear translocation and its activity in the HSR [12] . The RAS/MAPK pathway also regulates other transcription factors including C-MYC, which is important for the cell cycle, and the 40S ribosomal protein S6 kinase, which regulates translation, supporting a critical role for RAS/MAPK signaling to coordinate aspects of cell proliferation, protein biosynthesis and proteostasis. Likewise, the turnover of nuclear HSF1 and therefore the duration of the HSR are affected by the E3 ubiquitin ligase FBXW7 [20] , which also controls the levels of multiple cell cycle regulators including Cyclin E [29] . Ubiquitylation of HSF1 by FBXW7 is primed by phosphorylation of HSF1 at Ser303 and Ser307 by GSK3β and ERK1 respectively [20, 30, 31] , kinases involved in growth factor signaling (Figures 1&2), providing further support for the relationship between HSF1 and cell proliferation.
Collectively, these observations reveal that cell proliferation and the demands for protein synthesis are directly coordinated via HSF1 to prevent misfolded species from persisting in the cell.
In addition to cell proliferation, regulation of the HSR is influenced by the metabolic status of the cell. For example, in senescent human cells, the repression of the HSR is linked to reduced levels of the NAD + -dependent lysine deacetylase SIRT1.
In the absence of SIRT1 activity, HSF1 is rapidly acetylated by p300/CBP resulting in the release of HSF1 from heat shock promoters thereby dampening the HSR [8, 14] .
Additional evidence for the regulation of HSF1 by the metabolic state of the cell has emerged with AMP-activated protein kinase (AMPK), which phosphorylates HSF1 at Ser121 in conditions of metabolic stress therefore reducing the activity of the HSR by restricting nuclear entry of HSF1 [13] . AMPK can also regulate the HSR indirectly through its substrate PGC1α, a regulator of mitochondrial biogenesis that interacts with HSF1 during fasting in mouse livers and primary hepatocytes [17] , thereby repressing the HSR when energy availability is low. Furthermore, HSF1 is inactivated by amino acid deprivation [32] . A potential mechanism involves mTORC1, a key regulator of translation that depends on amino acid levels, which promotes HSF1 activity through phosphorylation at Ser326 [33] . Together, these findings provide evidence for a regulatory network that responds to the cellular NAD+/NADH, AMP/ATP and amino acid levels to link the potency of the HSR to energy availability and protein biogenesis ( Figure 2 ).
In metazoans the HSR is subject to cell non-autonomous regulation
Since the HSR is influenced by the proliferative and metabolic states of the cells, how do animals coordinate HSF1 activity among different cell types and tissues to achieve organismal protection against cell stress conditions? Studies in Caenorhabditis elegans (C. elegans) provided the initial evidence for the spatial and temporal control of HSF1 at the organismal level by cell non-autonomous regulation by neuronal signaling. . These findings together with the observations that the HSR is dampened in metabolic stress [13] , raise the intriguing possibility that HSF1 activity is linked to both energy availability and expenditure, and that HSF1 influences and is influenced by oscillations in the metabolic demands of different tissues and cell types.
It is noteworthy that, other than the pro-growth program of HSF1 in proteostasis and energy metabolism in diverse model systems, HSF1 appears to be involved in cell and tissue type specific transcriptional programs that are uncoupled from the HSR. FBXW7 has been suggested to stabilize nuclear-localized HSF1 for transcription in the absence of stress, thus promoting the metastatic potential of cancer cells [20] . On the contrary, PGC1α, which co-occupies with HSF1 at non HSR loci and represses HSF1 transcriptional activity, [17] decreases metastasis in prostate cancer [51] . It will therefore be of interest to determine how HSF1 is involved in the metabolic regulation of [53, 54] . It is known that epigenetic modulators including chromatin remodelers and histone modification enzymes are frequently mutated in cancer cells and underlies malignancy [55] . Similarly, elongation factors including components of the Super Elongation Complex [56] are abnormally recruited to genes in cancer cells. An important future direction is to test whether HSF1 serves as an adaptor between these two classes of factors and consequently contributes to the abnormal activation of pro-growth genes in cancer. As has been reported for the HSR, the alternative transcriptional programs of HSF1 are also subject to cell-type specific regulation with HSF1 directing the expression of different sets of genes in cancer cells and cancer-associated fibroblasts [43] . Currently, it is unclear how these cell-type specific HSF1 programs are coordinated but future work should reveal how different combinations of co-factors and alternate chromatin structures generate diverse transcriptomes of HSF1.
The alternate transcriptional programs regulated by HSF1, may share common features including expression of a small set of key chaperones and metabolic regulators, in addition to condition specific targets. Defining these HSF1 regulated programs under conditions distinct from acute heat shock, and comparing them with the HSR will provide a new system level understanding of how biological systems evolved to meet environmental and physiological challenges.
Concluding remarks and relevance to disease
Cellular and organismal health requires optimal proteostasis, for which HSF1 has an essential role to respond and protect against proteotoxic damage. Protein misfolding and aggregation underlies the pathologies of many age-related human diseases, most notably neurodegenerative and metabolic disorders [1] . For these diseases, the ability to restore and enhance different arms of the PN to prevent imbalance and suppress aggregation and proteotoxicity may show much promise. However, a greater challenge will be to achieve healthy proteostasis over long periods of life, which requires careful monitoring and managing of the quality control machinery through the use of folding and degradation sensors.
It is noteworthy that for certain protein conformational diseases, such as
Huntington's disease, the HSR is dysregulated [57] . The inability to respond to aggregation by activation of the HSR has been proposed to exacerbate disease progression through a feed forward mechanism [58] . It is well established that genetic or pharmacological activation of HSF1 can suppress proteotoxicity and ameliorate symptoms in various disease models [59] , and it is clear that in this context, increased HSF1 activity should be beneficial if carefully titrated. In addition to activation of HSF1, another potential strategy to engage the protective mechanism of HSF1 could be through the regulators of HSF1 that are affected in neurodegenerative diseases. For example, in mouse models of Huntington's Disease and Parkinson's Disease, the levels of the CK2 α' kinase and NEDD4 E3 ligase increase respectively in the presence of disease-related proteins [21, 22] , which causes degradation of HSF1. Therefore, stabilizing HSF1 through pharmacological inhibition of CK2 α' and NEDD4 could offer a complementary strategy to restore HSF1 and the HSR in disease.
The observations in cancer show that diverse tumors exhibit constitutive activation of HSF1 and elevated levels or altered interactions of chaperones. These changes have been suggested to contribute to oncogenesis and ability of cancer cells to compensate for genomic instability and elevated load of mutations in the expressed proteome [60, 61] . Thus for cancer, a strategy would be to reduce HSF1 activity [62] .
Inhibition of HSF1 has been shown to increase the vulnerability of rapidly dividing tumor cells to proteotoxic stress conditions [12] . 
BOX 1. HSF1 is essential for the HSR and proteostasis
The heat shock response (HSR) was initially discovered as a transcriptional response to elevated temperatures [63] , and is best known for the rapid and robust transcriptional induction by the evolutionarily conserved Heat Shock Factor 1 (HSF1).
The well-studied target genes of HSF1 in the HSR include molecular chaperones, that are essential for protein folding, to prevent misfolding and to restore the native conformation of misfolded proteins, and components of the ubiquitin proteasome system, that degrade damaged proteins and recycle amino acids. The subset of chaperones whose expression is heat shock inducible are also historically called heat shock proteins. The coordinated actions of these protein quality control genes restores protein homeostasis (proteostasis) when disrupted by heat shock [1] . While induction of the HSR is specific to elevated temperature stress, a closely related form of cell stress response involving HSF1 is induced when cells are exposed to other forms of environmental stress such as oxidants, heavy metals, and xenobiotics that cause protein damage and misfolding [2] , or by genetic perturbations that lead to errors in protein biogenesis and proteome imbalance [5] [6] [7] [8] . Likewise, the cellular response to heat shock includes diverse transcriptional and post-transcriptional events, many of which are independent of HSF1 [46, 54, 64] . Since its initial discovery, the HSR has evolved from its broad historical definition to a more specific terminology referring to the transcriptional program regulated by HSF1 in response to acute proteotoxic stress as occurs upon heat shock. While the full scope and connectivity of the HSR in eukaryotes is still not fully understood, it is clear that the HSF1-regulated HSR provides a cellular defense mechanism against protein damage, misfolding and aggregation in the cytoplasm and nucleus in parallel to the unfolded protein responses of the mitochondrion and endoplasm reticulum.
Trends
The activity of HSF1 is tuned to diverse cellular conditions that include the acute response to heat shock and other forms of cell stress conditions and extends to the proliferation and metabolic status of the cell.
The HSR can be regulated in a cell-non-autonomous manner through intertissue signaling to communicate stress signals and to ensure a coordinated organismal wide proteostatic response.
During development and in carcinogenesis, HSF1 directs transcriptional programs that are distinct from the HSR.
The transcriptional regulatory mechanism employed by HSF1 in development is uncoupled from the HSR; through partnership with other transcription factors. 
